bpc-157 oral Sublingual Oral vs Injectable BPC-157: Differences,
Description
Likewise, given that the gray matter is particularly vulnerable during the primary phase [44, 63], we should note that, from day 7, the controls presented with edema and the loss of motoneurons in the gray matter, disturbances that were largely counteracted in BPC 157-treated rats (Table 2 and Fig

Additional studies were obtained from references of identified studies, the Cochrane Library and the ISI Web of Knowledge

This is absolutely critical if you plan to store the reconstituted peptide and draw multiple doses from the same vial over a period of days or weeks

Sublingual absorption bypasses the gut entirely no intrinsic factor needed
